Celdara Medical, LLC articles
Celdara Medical, LLC (CM) is developing a portfolio of preclinical therapeutic assets, platforms, and companies. Each of these has a different development path, and we work with many different modalities, and in many different indications, but everything we do is singularly focused on saving lives and/or improving quality of life.
The successful Entrepreneur In Residence will identify one or more platforms/assets from CM’s current portfolio or our incoming innovation pipeline, e
Celdara Medical, LLC today announced that the National Cancer Institute of the National Institutes of Health (NIH) has awarded a Small Business Innovation Research (SBIR) Phase I award to fund the company’s proof of concept studies on a new platform to improve chimeric antigen receptor (CAR) T cells efficacy to treat solid tumors.
Dr. Joana Murad-Mabaera, who leads this effort, stated, “CAR T-based cellular products have been very effective against liquid tumors. Ho